P Salvato

Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:PolyC12U in the treatment of HIV infection

Kenneth Thompson, David R. Strayer, P Salvato et al. · European Journal of Clinical Microbiology & Infectious Diseases · 1996 · 89 citations

Double-blind Placebo-controlled Study, Medicine, Human Retrovirus +8

Changes in the 2-5A synthetase/RNase L antiviral pathway in a controlled clinical trial with poly(I)-poly(C12U) in chronic fatigue syndrome.

Robert J. Suhadolnik, N L Reichenbach, Patricia Hitzges et al. · PubMed · 1995 · 55 citations

Translational Medicine, Translational Pharmacology, Autoimmune Disease +14

‘Lyme disease’: ancient engine of an unrecognized borreliosis pandemic?

William T. Harvey, P Salvato · Medical Hypotheses · 2003 · 43 citations

Ancient Engine, Disease Outbreak, Epidemiology +2

Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV‐infected, therapy‐naïve patients: results of the EPIC study (CCR100136)^*

P. Yéni, Anthony LaMarca, Daniel Berger et al. · HIV Medicine · 2009 · 15 citations · Full text

Thymidine-analog and multi-nucleoside resistance mutations are observed in both zidovudine-naive and zidovudine-experienced subjects with viremia after treatment with stavudine-containing regimens.

Lisa Ross, Kenneth R. Henry, Dávid Paár et al. · PubMed · 2002 · 12 citations